CDL NUCLEAR TECHNOLOGIES, LLC

CDL Nuclear Technologies, LLC specializes in providing mobile diagnostic imaging services tailored to correctional healthcare environments, with a primary focus on ultrasound and stress testing for inmate populations. The contractor delivers non-personal diagnostic imaging solutions using mobile units equipped to perform echocardiography, cardiac stress testing, and general ultrasound examinations in federal prison facilities. Their technical expertise lies in deploying clinical imaging protocols under constrained operational conditions, ensuring compliance with medical standards while operating in secure, high-security correctional settings. Key differentiators include the ability to coordinate complex logistics for mobile medical deployments, maintain continuity of care across multiple federal institutions, and deliver timely diagnostic services without requiring inmate transport. The company maintains a consistent, long-term relationship with the Department of Justice, specifically supporting facilities under the Federal Bureau of Prisons. All awarded contracts are for diagnostic imaging services at FCI Loretto and FCI Elkton, indicating a deep operational familiarity with federal correctional healthcare infrastructure. Work is consistently structured as recurring delivery orders, suggesting a trusted, ongoing partnership where reliability and regulatory adherence are paramount. CDL Nuclear Technologies operates primarily under NAICS 621512 (Diagnostic Imaging Centers), reflecting its specialization in outpatient imaging services delivered via mobile platforms. While one contract falls under NAICS 621511 (Medical Laboratories), the overwhelming focus remains on imaging rather than lab-based diagnostics. This positions the contractor as a niche provider within the federal corrections healthcare market, serving a high-demand, low-resource segment requiring on-site, secure, and scalable imaging capabilities. The entity is structured as a 2L (small business) with no government certifications disclosed. Based in Wexford, Pennsylvania, its geographic footprint is centered on supporting federal correctional facilities across the eastern U.S., with a strategic emphasis on operational agility rather than broad national coverage. The company’s market positioning is defined by its ability to deliver specialized medical imaging services in highly regulated, non-traditional clinical environments.